203P Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer

Authors :: M. Muñoz Mateu
Laura Cortesi
M. Ulanska
J. Bayo
N. Martínez Jañez
E. Petru
T. Pinter
A.C.F. Rodrigues
G.R. Villanova
J. Ettl
Marina Elena Cazzaniga
C de Almeida
S. Morales Murillo
G. Freyer
R. Raymond
N. Cherciu
B.D. Kukielka-Budny
C. Ta Thanh Minh
M. Palacova
H. Bourgeois
Source :: Annals of Oncology. 32:S447
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Advanced breast
Cancer
Hematology
Vinorelbine
medicine.disease
law.invention
Randomized controlled trial
law
Internal medicine
medicine
Single agent
In patient
First line chemotherapy
business
medicine.drug

Full Text Access

Tools